BRNS
Price
$0.70
Change
-$0.00 (-0.00%)
Updated
Dec 26 closing price
Capitalization
28.75M
83 days until earnings call
Intraday BUY SELL Signals
TARA
Price
$5.55
Change
+$0.06 (+1.09%)
Updated
Dec 26 closing price
Capitalization
297.41M
73 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BRNS vs TARA

Header iconBRNS vs TARA Comparison
Open Charts BRNS vs TARABanner chart's image
Barinthus Biotherapeutics
Price$0.70
Change-$0.00 (-0.00%)
Volume$159.89K
Capitalization28.75M
Protara Therapeutics
Price$5.55
Change+$0.06 (+1.09%)
Volume$384.24K
Capitalization297.41M
BRNS vs TARA Comparison Chart in %
BRNS
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BRNS vs. TARA commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a StrongBuy and TARA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (BRNS: $0.70 vs. TARA: $5.55)
Brand notoriety: BRNS and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 159% vs. TARA: 47%
Market capitalization -- BRNS: $28.75M vs. TARA: $297.41M
BRNS [@Biotechnology] is valued at $28.75M. TARA’s [@Biotechnology] market capitalization is $297.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, TARA is a better buy in the long-term than BRNS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 4 TA indicator(s) are bullish while TARA’s TA Score has 2 bullish TA indicator(s).

  • BRNS’s TA Score: 4 bullish, 4 bearish.
  • TARA’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, BRNS is a better buy in the short-term than TARA.

Price Growth

BRNS (@Biotechnology) experienced а -4.71% price change this week, while TARA (@Biotechnology) price change was +5.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

BRNS is expected to report earnings on Mar 20, 2026.

TARA is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARA($297M) has a higher market cap than BRNS($28.8M). TARA YTD gains are higher at: 5.114 vs. BRNS (-41.705). TARA has higher annual earnings (EBITDA): -59.43M vs. BRNS (-69.65M). TARA has more cash in the bank: 133M vs. BRNS (74.3M). TARA has less debt than BRNS: TARA (3.66M) vs BRNS (11.6M). BRNS (0) and TARA (0) have equivalent revenues.
BRNSTARABRNS / TARA
Capitalization28.8M297M10%
EBITDA-69.65M-59.43M117%
Gain YTD-41.7055.114-816%
P/E RatioN/AN/A-
Revenue00-
Total Cash74.3M133M56%
Total Debt11.6M3.66M317%
FUNDAMENTALS RATINGS
TARA: Fundamental Ratings
TARA
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRNSTARA
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTES138.070.91
+0.66%
NetEase
MYFW26.250.13
+0.50%
First Western Financial
KMX39.270.09
+0.23%
CarMax
NGL9.39-0.47
-4.77%
NGL Energy Partners LP
SNTI1.06-0.09
-7.83%
Senti Biosciences Inc.

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
+0.38%
SLNO - BRNS
56%
Loosely correlated
-3.03%
NGNE - BRNS
51%
Loosely correlated
-0.30%
NEUP - BRNS
50%
Loosely correlated
-1.85%
TARA - BRNS
35%
Loosely correlated
+1.09%
BGMS - BRNS
31%
Poorly correlated
+4.23%
More